vs

Side-by-side financial comparison of Vyome Holdings, Inc (HIND) and Qudian Inc. (HTT). Click either name above to swap in a different company.

Vyome Holdings, Inc is the larger business by last-quarter revenue ($1.2M vs $1.1M, roughly 1.1× Qudian Inc.). Qudian Inc. runs the higher net margin — 239.8% vs -211.8%, a 451.5% gap on every dollar of revenue.

Vyome Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutic solutions for a range of dermatological conditions. Its product pipeline targets unmet medical needs related to acne, atopic dermatitis, and chronic fungal infections, with primary operations and market presence across North America and South Asia.

Qudian Inc. is a China-based fintech service provider that mainly offers small consumer credit solutions, risk management technical services, and related digital financial products. Its core target users are young mass consumers across China, with all key business operations focused on the domestic Chinese market.

HIND vs HTT — Head-to-Head

Bigger by revenue
HIND
HIND
1.1× larger
HIND
$1.2M
$1.1M
HTT
Higher net margin
HTT
HTT
451.5% more per $
HTT
239.8%
-211.8%
HIND

Income Statement — Q2 FY2025 vs Q3 FY2024

Metric
HIND
HIND
HTT
HTT
Revenue
$1.2M
$1.1M
Net Profit
$-2.6M
$2.6M
Gross Margin
48.2%
11.1%
Operating Margin
-222.4%
-121.7%
Net Margin
-211.8%
239.8%
Revenue YoY
-36.8%
Net Profit YoY
-64.9%
EPS (diluted)
$-2.25
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIND
HIND
HTT
HTT
Q2 25
$1.2M
Q1 25
$1.1M
Q4 24
$1.8M
Q3 24
$2.3M
$1.1M
Q2 24
$2.0M
$1.0M
Q1 24
$1.9M
$1.1M
Q4 23
$2.0M
Q3 23
$2.2M
$559.9K
Net Profit
HIND
HIND
HTT
HTT
Q2 25
$-2.6M
Q1 25
$1.5M
Q4 24
$2.9M
Q3 24
$-547.8K
$2.6M
Q2 24
$-1.6M
$1.9M
Q1 24
$-2.2M
$-1.4M
Q4 23
$-1.7M
Q3 23
$-3.5M
$-3.4M
Gross Margin
HIND
HIND
HTT
HTT
Q2 25
48.2%
Q1 25
61.2%
Q4 24
-118.6%
Q3 24
1.6%
11.1%
Q2 24
57.7%
13.3%
Q1 24
59.9%
Q4 23
92.9%
Q3 23
59.8%
Operating Margin
HIND
HIND
HTT
HTT
Q2 25
-222.4%
Q1 25
-198.2%
Q4 24
Q3 24
-12.3%
-121.7%
Q2 24
-104.5%
-107.6%
Q1 24
-113.7%
-129.9%
Q4 23
-95.7%
Q3 23
-180.0%
-340.6%
Net Margin
HIND
HIND
HTT
HTT
Q2 25
-211.8%
Q1 25
132.4%
Q4 24
160.0%
Q3 24
-23.9%
239.8%
Q2 24
-81.2%
187.1%
Q1 24
-112.8%
-131.8%
Q4 23
-85.7%
Q3 23
-164.0%
-612.3%
EPS (diluted)
HIND
HIND
HTT
HTT
Q2 25
$-2.25
Q1 25
$18.98
Q4 24
$-4355.36
Q3 24
$-1419.10
$0.01
Q2 24
$-91.56
$0.01
Q1 24
$-135.37
$-0.01
Q4 23
$-48.87
Q3 23
$-59.36
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIND
HIND
HTT
HTT
Cash + ST InvestmentsLiquidity on hand
$104.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-5.0M
$225.2M
Total Assets
$246.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIND
HIND
HTT
HTT
Q2 25
Q1 25
$2.5M
Q4 24
$101.9K
Q3 24
$743.0K
$104.9M
Q2 24
$12.0K
$112.8M
Q1 24
$2.4M
$140.6M
Q4 23
$4.5M
Q3 23
$1.4M
$183.4M
Stockholders' Equity
HIND
HIND
HTT
HTT
Q2 25
$-5.0M
Q1 25
$1.2M
Q4 24
$-4.4M
Q3 24
$1.5M
$225.2M
Q2 24
$-4.0M
$217.5M
Q1 24
$4.5M
$218.9M
Q4 23
$-6.2M
Q3 23
$3.1M
$226.0M
Total Assets
HIND
HIND
HTT
HTT
Q2 25
Q1 25
$6.5M
Q4 24
$1.4M
Q3 24
$1.3M
$246.8M
Q2 24
$-614.0K
$227.9M
Q1 24
$8.2M
$234.9M
Q4 23
$10.7M
Q3 23
$7.8M
$239.4M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons